Campylobacter jejuni is a leading cause of bacterial gastroenteritis worldwide; however, the molecular determinants associated with symptomatic infection remain incompletely understood. In this study, an immunoproteomic approach was applied to characterize the antigenic landscape of C. jejuni during acute campylobacteriosis and to identify infection-associated proteins targeted by the human humoral immune response. Sera from patients with laboratory-confirmed acute campylobacteriosis (Group A) and asymptomatic individuals without recent gastrointestinal disease (Group B) were used to immunocapture bacterial proteins, followed by nano-liquid chromatography-tandem mass spectrometry analysis. A total of 418 and 517 immunoreactive proteins were identified in Groups A and B, respectively, with a large shared core repertoire, indicating extensive background immune recognition of conserved bacterial components. Functional annotation revealed that metabolic enzymes and ribosomal proteins dominated the immunoproteome in both groups. However, semi-quantitative emPAI analysis identified selective differences associated with acute infection. Group A sera preferentially recognized proteins involved in stress response, motility, secretion, and virulence-related functions, whereas Group B sera predominantly recognized housekeeping proteins. Bioinformatic prediction and network analyses identified immunoreactive proteins with features compatible with secretion-associated virulence factors, including proteins related to the flagellar export apparatus and the cytolethal distending toxin complex. Additionally, several immunoreactive proteins carried C-terminal acidic E-Block-like motifs previously described in Type IV secretion system effectors from other bacterial pathogens. Although the present approach does not directly demonstrate secretion, surface exposure, or translocation of the predicted proteins, these findings provide insight into infection-associated immune recognition patterns and identify candidate virulence-associated antigens that warrant future experimental validation.
Nonsystemic vasculitic neuropathy (NSVN) is a rare disorder characterized by inflammation of the vessels supplying peripheral nerves, resulting in isolated involvement of the peripheral nervous system. Patients typically present with paresis and hypoesthesia or anesthesia. Although usually painful, approximately 20% of cases are painless. The condition generally has a subacute to chronic onset and often presents as distal or proximal polyradiculopathy. In a retrospective cohort of 60 patients, 80% showed an asymmetric pattern. This report describes a patient with NSVN presenting atypically with a subacute, symmetrical neuropathy without neuralgic pain several months after a presentation similar to Tolosa–Hunt syndrome.
OBJECTIVE:To evaluate the utility of the Fibromyalgia Survey Questionnaire (FSQ) as a screening tool for fibromyalgia (FM) in patients with inflammatory arthritis (IA) and to determine optimal cutoff points according to arthritis disease activity. METHODS:Patients with rheumatoid arthritis (RA), axial spondyloarthritis (SpA), and psoriatic arthritis (PsA), with and without comorbid fibromyalgia (FM) at a 1:1 ratio were invited to participate in this cross-sectional study. FM status was defined by an expert physician's diagnosis. Disease activity indexes were recorded. Participants completed the FSQ through a structured online interview. ROC analysis and the area under the curve (AUC) were calculated to identify the optimal FSQ cutoff values. RESULTS:A total of 152 IA patients were included (72% RA, 11% SpA, and 17% PsA), 51% of whom had comorbid FM. The ability of the FSQ to differentiate comorbid FM among patients in remission or with low disease activity (n=80) was high (AUC=0.896), showing 88% sensitivity and 88% specificity at a cutoff >12. In contrast, the FSQ performance was lower in patients with moderate to very high disease activity (n=72, AUC=0.695), with 83% sensitivity and 56% specificity at a cutoff >15. CONCLUSIONS:The FSQ is a useful screening tool for identifying comorbid FM in IA patients with low disease activity or in remission, with performance comparable to the general population (cutoff value >12). Results should be interpreted cautiously in those with active disease. These findings may facilitate the recognition and management of comorbid FM in IA patients.
Radiologists have a central role in building understanding of many diseases. In multidisciplinary settings, medical imaging has a role in diagnosing, assessing severity, monitoring progress and delineating anatomical structures involved in diseases. Imaging also helps to elucidate models of disease pathogenesis. In this review, imaging features of COVID-19 lung disease are analysed in the context of pathophysiological processes in different phases of the disease. Radiological evidence is presented for the central role of vasculopathic phenomena in both the acute and post-acute phases of COVID-19. From the outset of the COVID-19 pandemic, a lack of formal collaborative interdisciplinary systems to build models of pathophysiology led to widespread misunderstanding of the lung disease. Specifically, the lack of a systematic multidisciplinary approach to share concepts relating to radiological evidence with collaborators from other medical and scientific fields led to the use of terminology which was, and remains, potentially inappropriate or misleading. In conclusion, imaging is essential to multidisciplinary understanding of COVID-19 vascular pathophysiology. Current evidence should lead to adapted diagnostic guidelines for long COVID. Formation of collaborative systems to build interdisciplinary understanding of disease pathogenesis across all medical and scientific specialties should be a priority at the outset of any future pandemic.
El ejercicio actual de la medicina se encuentra sometido a diversas regulaciones legales y reglamentarias, a aspectos económicos y técnicos, como también a factores externos y aquellos internos propios de la ética personal y profesional. Se examinan estas circunstancias y cómo aquellas interactúan, positiva o negativamente, en el accionar médico, limitando la libertad del profesional para tomar decisiones. La libertad profesional del médico consiste en la capacidad de ejercer su autonomía para elegir lo correcto en relación con su paciente, teniendo implícita la responsabilidad sobre ello. Se discuten el papel de las guías clínicas, como el de la autoridad y las acciones de control, los efectos de los recursos limitados, el acceso a la ficha clínica, así como el de la condición física y moral personal del médico. Se destaca el papel de la lex artis para el cumplimiento de la finalidad de la medicina en relación con el cuidado de los pacientes.